Cypress Development Begins Phase 2 Exploration at Clayton Valley Lithium Project, Nevada
Apr 05, 2016 12:00 pm UTC| Business
VANCOUVER, British Columbia, April 05, 2016 -- Cypress Development Corp. (TSX-V:CYP) (OTC Pink:CYDVF) (Frankfurt:C1Z1) (“Cypress” or the “Company”) is pleased to report the beginning of its Phase 2 exploration program...
Interleukin Genetics Announces Clarification of Commercial Test Compliance
Apr 05, 2016 12:00 pm UTC| Business
WALTHAM, Mass., April 05, 2016 -- Interleukin Genetics, Inc. (OTCQB:ILIU), a life sciences company focused on developing and marketing proprietary genetic tests for chronic diseases and health-related conditions, today...
Cara Therapeutics to Webcast Presentation at the 15th Annual Needham Healthcare Conference
Apr 05, 2016 12:00 pm UTC| Business
SHELTON, Conn., April 05, 2016 -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biotechnology company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively...
Apr 05, 2016 12:00 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., April 05, 2016 -- Achaogen, Inc. (NASDAQ:AKAO), a clinical-stage biopharmaceutical company developing novel antibacterials addressing multi-drug resistant (MDR) gram-negative infections,...
Wix.com Recognized as Google Apps Online Partner of the Year
Apr 05, 2016 12:00 pm UTC| Business
TEL AVIV, Israel, April 05, 2016 -- Leading web development platform Wix.com (Nasdaq:WIX) was recognized by Google for Work as its Google Apps Online Partner of the Year for 2015. The accolade marks the second...
Manhattan Associates Sets the Stage for Next Gen Distribution Management at MODEX 2016
Apr 05, 2016 12:00 pm UTC| Business
ATLANTA, April 05, 2016 -- Manhattan Associates, Inc. (NASDAQ:MANH) today announced its latest Slotting Optimization offering at MODEX 2016 in Atlanta. Featuring an enhanced, state-of-the-art algorithm; mobile...
Karyopharm to Present at the 15th Annual Needham Healthcare Conference
Apr 05, 2016 12:00 pm UTC| Business
NEWTON, Mass., April 05, 2016 -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage pharmaceutical company, today announced that Michael G. Kauffmann, MD, PhD, Chief Executive Officer of Karyopharm, is...
Trump's Hammer on Russian Oil Buyers: 500% Tariffs Loom